Trial Outcomes & Findings for Home Usability Study of the SARS-CoV-2 (COVID-19) Test (NCT NCT04395391)

NCT ID: NCT04395391

Last Updated: 2023-12-13

Results Overview

The percent of samples from the fully enrolled cohort to return a valid SARS-CoV-2 test result (positive, not detected, or inconclusive)

Recruitment status

COMPLETED

Target enrollment

30 participants

Primary outcome timeframe

Subjects are assessed at enrollment

Results posted on

2023-12-13

Participant Flow

Participant milestones

Participant milestones
Measure
Volunteers
Men and women who had no prior medical or laboratory training, no prior experience with COVID-19 self-collection, or no prior SARS-CoV-2 testing.
Overall Study
STARTED
30
Overall Study
COMPLETED
30
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Home Usability Study of the SARS-CoV-2 (COVID-19) Test

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Volunteers
n=30 Participants
Men and women who had no prior medical or laboratory training, no prior experience with COVID-19 self-collection, or no prior SARS-CoV-2 testing.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
18 Participants
n=5 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
Race (NIH/OMB)
White
26 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
30 participants
n=5 Participants
Level of Education
College degree, or higher
23 Participants
n=5 Participants
Level of Education
Other level of education
7 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Subjects are assessed at enrollment

Population: Each participant only completed one test.

The percent of samples from the fully enrolled cohort to return a valid SARS-CoV-2 test result (positive, not detected, or inconclusive)

Outcome measures

Outcome measures
Measure
Volunteers
n=30 Participants
Men and women who had no prior medical or laboratory training, no prior experience with COVID-19 self-collection, or no prior SARS-CoV-2 testing.
Valid SARS-CoV-2 Test
30 Participants

Adverse Events

Volunteers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alexandra Massoud, Vice President of Clinical Affairs

Exact Sciences

Phone: 608-284-5700

Results disclosure agreements

  • Principal investigator is a sponsor employee Principal Investigator agreed that they shall not, without the Sponsor's prior written consent, independently publish, publicly disclose, present or discuss any results of or information pertaining to the activities conducted under their agreement for a period of one (1) year following completion of the Study.
  • Publication restrictions are in place

Restriction type: OTHER